Prostaglandin E(2) promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization

Amplification of MYCN is the most well-known prognostic marker of neuroblastoma risk classification, but still is only observed in 25% of cases. Recent evidence points to the cyclic adenosine monophosphate (cAMP) elevating ligand prostaglandin E(2) (PGE(2)) and β-catenin as two novel players in neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Sepp R, Holman, Rian, Hedemann, Ilja, Frankes, Ewoud, Elzinga, Carolina R S, Timens, Wim, Gosens, Reinoud, de Bont, Eveline S, Schmidt, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288364/
https://www.ncbi.nlm.nih.gov/pubmed/25266063
http://dx.doi.org/10.1111/jcmm.12418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288364/
https://www.ncbi.nlm.nih.gov/pubmed/25266063
http://dx.doi.org/10.1111/jcmm.12418

Ejemplares similares